# Systems Biological Assessment of Statin Effect on Vaccine Responses

> **NCT06024096** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 63 (actual)

## Conditions studied

- Vaccine Response

## Interventions

- **DRUG:** Atorvastatin
- **BIOLOGICAL:** Quadrivalent seasonal influenza vaccine

## Key facts

- **NCT ID:** NCT06024096
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-20
- **Primary completion:** 2024-12-16
- **Final completion:** 2024-12-16
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06024096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06024096, "Systems Biological Assessment of Statin Effect on Vaccine Responses". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06024096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*